Abstract
The objective of this study is to describe a pharmacotherapy form model to monitor patients' pharmacotherapeutic follow-up (PF) on antiretroviral therapy in a specialized center of Ceara, Brazil. Description comprises its structure up to application. The preparation and application of the PF registration model were carried out by means of a focal group. The following steps were used for the draft: 1. Review of the literature; 2. Diagnosis of place where pharmaceutical care was undertaken; 3. Choice of the PF method; 4. Selection of clinical indicators; 5. Evaluation by a committee of experts; 6. Development of a standard functional procedure with timetable and evaluation frequency of the tool's different sections or blocks. 7. Pilot study for evaluation of the form with 25 patients. PF form featured six sections comprising patient's personal data, pharmaceutical anamnesis and records of adherence evaluation, etc. The description and format of the sections are presented in current essay. Further, 322 issues related to antiretroviral drugs were reported during form filling. The multi- section PF form seemed appropriate and applicable for the report of issues related to antiretroviral drugs in HIV positive patients. It was also a helpful guide for pharmaceutical interventions by a multiprofessional team in specialized healthcare settings.
Highlights
The consequences of infection by human immunodeficiency virus (HIV) may be decreased or controlled by currently well-established antiretroviral therapy (ART)
Medicine-related issues (MRIs) are highlighted within the antiretroviral treatment, especially patients’ adhesion to treatment and the decrease of morbidity-mortality rates directly associated with HIV infection
The care center for the development of current PHC service was selected by a working team of professors in Hospital Pharmacy, Pharmaco-economy, Applied Pharmacology, Pharmaceutical Care, pharmacists specialized in AIDS service in the state and members of the Study Center in Pharmaceutical Care (Ceatenf) of the Federal University of Ceará
Summary
The consequences of infection by human immunodeficiency virus (HIV) may be decreased or controlled by currently well-established antiretroviral therapy (ART). Lack of posology facility, the great number of medicines for each therapy, memory-related factors, distraction, Acta Scientiarum. Health Sciences routine interruptions and negative physiological state associated with adverse conditions caused by drugs are risk factors for the non-compliance to treatment (CHESNEY et al, 2000). Social obstacles and adhesion difficulties to antiretroviral treatment are taken into account, the patients’ follow-up facilities by a multidisciplinary team are structured by the aggregation of specialized health. Medicine-related issues (MRIs) are highlighted within the antiretroviral treatment, especially patients’ adhesion to treatment and the decrease of morbidity-mortality rates directly associated with HIV infection. Pharmacotherapeutic care services or Pharmaceutical Care programs require more actions by the pharmacist in individualized pharmacotherapeutic needs and associated factors. Since the service structure within the Brazilian health system is still a challenge, the strategies that facilitate their materialization with regard to structure, processes and report of results cannot be postponed
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
